Literature DB >> 19501160

Breast cancer resistance protein (BCRP/ABCG2): new inhibitors and QSAR studies by a 3D linear solvation energy approach.

Edwige Nicolle1, Julien Boccard, David Guilet, Marie-Geneviève Dijoux-Franca, Fabien Zelefac, Sira Macalou, Jeanne Grosselin, Julien Schmidt, Pierre-Alain Carrupt, Attilio Di Pietro, Ahcène Boumendjel.   

Abstract

A series of compounds derived from naturally occurring flavonoids and synthetic analogs have been evaluated on cell lines overexpressing the wild-type breast cancer resistance protein (BCRP/ABCG2) half-transporter. Human ABCG2-transfected cells were used for screening their inhibitory activity. Five new natural compounds obtained from Morus mesozygia Stapf and one synthetic chromone, comprising a flavonoidic scaffold, were also evaluated. Based on the results obtained with a total of 34 compounds, a 3D linear solvation energy QSAR was investigated by VolSurf descriptors of molecular-interaction fields (MIFs) related to hydrophobic-interaction forces, polarisability and hydrogen-bonding capacity. Accuracy of the constructed 3D-QSAR model was attested by a correlation coefficient r(2) of 0.77. Shape parameters and hydrophobicity were revealed to be major physicochemical parameters responsible for the inhibition activity of flavonoid derivatives and synthetic analogs towards ABCG2, whereas hydrogen-bond donor capacity appeared highly unfavorable.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19501160     DOI: 10.1016/j.ejps.2009.05.012

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN: 0928-0987            Impact factor:   4.384


  9 in total

1.  Investigation of chalcones as selective inhibitors of the breast cancer resistance protein: critical role of methoxylation in both inhibition potency and cytotoxicity.

Authors:  Glaucio Valdameri; Charlotte Gauthier; Raphaël Terreux; Rémy Kachadourian; Brian J Day; Sheila M B Winnischofer; Maria E M Rocha; Véronique Frachet; Xavier Ronot; Attilio Di Pietro; Ahcène Boumendjel
Journal:  J Med Chem       Date:  2012-04-02       Impact factor: 7.446

Review 2.  Potential of Central, Eastern and Western Africa Medicinal Plants for Cancer Therapy: Spotlight on Resistant Cells and Molecular Targets.

Authors:  Armelle T Mbaveng; Victor Kuete; Thomas Efferth
Journal:  Front Pharmacol       Date:  2017-06-02       Impact factor: 5.810

Review 3.  Structure and function of the human breast cancer resistance protein (BCRP/ABCG2).

Authors:  Zhanglin Ni; Zsolt Bikadi; Mark F Rosenberg; Qingcheng Mao
Journal:  Curr Drug Metab       Date:  2010-09       Impact factor: 3.731

Review 4.  Marine natural products as breast cancer resistance protein inhibitors.

Authors:  Lilia Cherigo; Dioxelis Lopez; Sergio Martinez-Luis
Journal:  Mar Drugs       Date:  2015-04-03       Impact factor: 5.118

5.  Bafetinib (INNO-406) reverses multidrug resistance by inhibiting the efflux function of ABCB1 and ABCG2 transporters.

Authors:  Yun-Kai Zhang; Guan-Nan Zhang; Yi-Jun Wang; Bhargav A Patel; Tanaji T Talele; Dong-Hua Yang; Zhe-Sheng Chen
Journal:  Sci Rep       Date:  2016-05-09       Impact factor: 4.379

Review 6.  The Effects of Synthetically Modified Natural Compounds on ABC Transporters.

Authors:  Daniel Dantzic; Pawan Noel; Fabrice Merien; Dong-Xu Liu; Jun Lu; Haiyong Han; Mark J McKeage; Yan Li
Journal:  Pharmaceutics       Date:  2018-08-09       Impact factor: 6.321

7.  ADMET evaluation in drug discovery. 20. Prediction of breast cancer resistance protein inhibition through machine learning.

Authors:  Dejun Jiang; Tailong Lei; Zhe Wang; Chao Shen; Dongsheng Cao; Tingjun Hou
Journal:  J Cheminform       Date:  2020-03-05       Impact factor: 5.514

8.  Nilotinib potentiates anticancer drug sensitivity in murine ABCB1-, ABCG2-, and ABCC10-multidrug resistance xenograft models.

Authors:  Amit K Tiwari; Kamlesh Sodani; Chun-Ling Dai; Alaa H Abuznait; Satyakam Singh; Zhi-Jie Xiao; Atish Patel; Tanaji T Talele; Liwu Fu; Amal Kaddoumi; James M Gallo; Zhe-Sheng Chen
Journal:  Cancer Lett       Date:  2012-10-09       Impact factor: 8.679

9.  New structure-activity relationships of chalcone inhibitors of breast cancer resistance protein: polyspecificity toward inhibition and critical substitutions against cytotoxicity.

Authors:  Luciana Pereira Rangel; Evelyn Winter; Charlotte Gauthier; Raphaël Terreux; Louise D Chiaradia-Delatorre; Alessandra Mascarello; Ricardo J Nunes; Rosendo A Yunes; Tania B Creczynski-Pasa; Sira Macalou; Doriane Lorendeau; Hélène Baubichon-Cortay; Antonio Ferreira-Pereira; Attilio Di Pietro
Journal:  Drug Des Devel Ther       Date:  2013-09-30       Impact factor: 4.162

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.